Literature DB >> 16920811

Spontaneous atrial fibrillation initiated by triggered activity near the pulmonary veins in aged rats subjected to glycolytic inhibition.

Norihiko Ono1, Hideki Hayashi, Ayaka Kawase, Shien-Fong Lin, Hongmei Li, James N Weiss, Peng-Sheng Chen, Hrayr S Karagueuzian.   

Abstract

Aging and glycolytic inhibition (GI) are known to alter intracellular calcium ion (Ca(i)(2+)) handling in cardiac myocytes, causing early afterpotentials (EADs) and delayed afterpotentials. We hypothesized that aging and GI interact synergistically in intact hearts to generate EADs and triggered activity leading to atrial fibrillation (AF). We studied isolated and Langendorff-perfused hearts of young (age 3-5 mo, N = 8) and old (age 27-29 mo, N = 14) rats subjected to GI (0 glucose + 10 mmol/l pyruvate). Epicardial atrial activation maps were constructed using optical action potentials, while simultaneously monitoring Ca(i)(2+) by means of dual-voltage and calcium-sensitive fluorescent dyes. During GI, spontaneous AF occurred in 13 of 14 old but in no young rats. AF was initiated by EAD-induced triggered activity at the left atrial pulmonary vein junction (LA-PVJ). The triggered activity initially propagated as single wave front, but within 1 s degenerated into multiple wavelets. The EADs and triggered activity in the old atria were associated with significantly elevated diastolic Ca(i)(2+) levels at the LA-PVJ, where the time constant tau of the Ca(i)(2+) transient decline and action potential duration were significantly (P < 0.01) prolonged compared with atrial sites 5 mm away from LA-PVJ. During GI and rapid atrial pacing, spatially discordant APD and Ca(i)(2+) transient alternans developed in the old but not young atria, leading to AF. Atria in old rats had significantly more fibrotic tissue than atria in young rats. We conclude that GI interacts with the aged and fibrotic atria to amplify Ca(i)(2+) handling abnormalities that facilitate EAD-mediated triggered activity and AF.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16920811     DOI: 10.1152/ajpheart.00445.2006

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  31 in total

1.  AGE-RAGE Stress in the Pathophysiology of Atrial Fibrillation and Its Treatment.

Authors:  Kailash Prasad
Journal:  Int J Angiol       Date:  2019-12-09

2.  Cardiac fibrosis as a determinant of ventricular tachyarrhythmias.

Authors:  Norishige Morita; William J Mandel; Yoshinori Kobayashi; Hrayr S Karagueuzian
Journal:  J Arrhythm       Date:  2014-12-01

3.  Chasing with ranolazine pulmonary vein afterpotentials before it's too late.

Authors:  Hrayr S Karagueuzian
Journal:  Heart Rhythm       Date:  2008-03-27       Impact factor: 6.343

4.  Triggered firing and atrial fibrillation in transgenic mice with selective atrial fibrosis induced by overexpression of TGF-β1.

Authors:  Eue-Keun Choi; Po-Cheng Chang; Young-Soo Lee; Shien-Fong Lin; Wuqiang Zhu; Mitsunori Maruyama; Michael C Fishbein; Zhenhui Chen; Michael Rubart-von der Lohe; Loren J Field; Peng-Sheng Chen
Journal:  Circ J       Date:  2012-03-22       Impact factor: 2.993

5.  Left Atrial Volume and Pulmonary Artery Diameter Are Noninvasive Measures of Age-Related Diastolic Dysfunction in Mice.

Authors:  Guillermo Medrano; Jesus Hermosillo-Rodriguez; Thuy Pham; Alejandro Granillo; Craig J Hartley; Anilkumar Reddy; Patricia Mejia Osuna; Mark L Entman; George E Taffet
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-10-28       Impact factor: 6.053

6.  Bifurcation theory and cardiac arrhythmias.

Authors:  Hrayr S Karagueuzian; Hayk Stepanyan; William J Mandel
Journal:  Am J Cardiovasc Dis       Date:  2013-02-17

7.  Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop.

Authors:  Emelia J Benjamin; Peng-Sheng Chen; Diane E Bild; Alice M Mascette; Christine M Albert; Alvaro Alonso; Hugh Calkins; Stuart J Connolly; Anne B Curtis; Dawood Darbar; Patrick T Ellinor; Alan S Go; Nora F Goldschlager; Susan R Heckbert; José Jalife; Charles R Kerr; Daniel Levy; Donald M Lloyd-Jones; Barry M Massie; Stanley Nattel; Jeffrey E Olgin; Douglas L Packer; Sunny S Po; Teresa S M Tsang; David R Van Wagoner; Albert L Waldo; D George Wyse
Journal:  Circulation       Date:  2009-02-03       Impact factor: 29.690

8.  The effect of ranolazine on maintaining sinus rhythm in patients with resistant atrial fibrillation.

Authors:  David K Murdock; Naomi Overton; Mary Kersten; Jeff Kaliebe; Fausto Devecchi
Journal:  Indian Pacing Electrophysiol J       Date:  2008-08-01

Review 9.  Aged atria: electrical remodeling conducive to atrial fibrillation.

Authors:  Wen Dun; Penelope A Boyden
Journal:  J Interv Card Electrophysiol       Date:  2009-03-12       Impact factor: 1.900

10.  The use of oral ranolazine to convert new or paroxysmal atrial fibrillation: a review of experience with implications for possible "pill in the pocket" approach to atrial fibrillation.

Authors:  David K Murdock; Mary Kersten; Jeff Kaliebe; German Larrain
Journal:  Indian Pacing Electrophysiol J       Date:  2009-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.